BRIEF published on 12/13/2024 at 08:10, 1 year 9 months ago Nyxoah lance la thérapie Genio® en Angleterre Apnée Obstructive Du Sommeil Nyxoah SA Lancement Sur Le Marché Thérapie Genio® Service National De Santé D'Angleterre
BRIEF published on 12/13/2024 at 08:10, 1 year 9 months ago Nyxoah Launches Genio® Therapy in England NHS England Obstructive Sleep Apnea Nyxoah SA Market Launch Genio® Therapy
PRESS RELEASE published on 12/13/2024 at 08:05, 1 year 9 months ago Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England Nyxoah announces commercial launch of Genio Innovative Therapy in England with successful implants at UCLH. Genio system covered under NHS SSDP for OSA patients Nyxoah Genio Innovative Therapy England OSA
BRIEF published on 11/06/2024 at 22:10, 1 year 10 months ago Nyxoah publie ses résultats financiers du troisième trimestre 2024 Résultats Financiers Approbation De La FDA Situation De Trésorerie Apnée Obstructive Du Sommeil Commercialisation Aux États-Unis
BRIEF published on 11/06/2024 at 22:10, 1 year 10 months ago Nyxoah Reports Third Quarter 2024 Financial Results Financial Results Cash Position FDA Approval Obstructive Sleep Apnea U.S. Commercialization
PRESS RELEASE published on 11/06/2024 at 22:05, 1 year 10 months ago Nyxoah Reports Third Quarter Financial and Operating Results Nyxoah SA reports third quarter financial and operating results, with FDA approval on track for Q1 2025 and strengthening of U.S. commercial team. Company fully funded until mid-2026 Financial Results FDA Approval Sleep Apnea Nyxoah U.S. Commercial Team
BRIEF published on 10/08/2024 at 14:05, 1 year 11 months ago Nyxoah Secures $27 Million in At-the-Market Offering Financing U.S. Market Nyxoah Neuromodulation Healthcare Investor
BRIEF published on 10/08/2024 at 14:05, 1 year 11 months ago Nyxoah obtient 27 millions de dollars lors d'une offre sur le marché Financement Marché Américain Nyxoah Neuromodulation Investisseur Dans Le Secteur De La Santé
PRESS RELEASE published on 10/08/2024 at 14:00, 1 year 11 months ago Nyxoah Raises $27 Million through its At-the-Market Offering Nyxoah raises $27 million through its At-the-Market Offering, strengthening balance sheet and U.S. focus. New investment from U.S. healthcare investor Financing At-the-market Offering Nyxoah Obstructive Sleep Apnea Healthcare Investor
BRIEF published on 09/27/2024 at 22:35, 1 year 11 months ago Nyxoah présente les données prometteuses de l'étude DREAM à l'ISSS 2024 Approbation De La FDA Apnée Obstructive Du Sommeil Données Cliniques Étude DREAM Stimulation Génio
Published on 09/25/2026 at 07:30, 4 hours 54 minutes ago Tocvan Reports Positive Closed-Circuit Column Leach Results at Gran Pilar
Published on 09/25/2026 at 00:30, 11 hours 54 minutes ago Viemed Healthcare Announces Adoption of Automatic Securities Disposition Plan by President Michael Moore
Published on 09/25/2026 at 00:15, 12 hours 9 minutes ago CoTec Holdings Corp. Announces Extension of Private Placement of Unsecured Convertible Debentures
Published on 09/24/2026 at 22:01, 14 hours 23 minutes ago Fermi Selects CBRE to Operate and Maintain Its First Data Center
Published on 09/25/2026 at 10:00, 2 hours 24 minutes ago AI and supply chains open new pathways to systemic stress as risks become more interconnected, find Swiss Re Institute and LSE
Published on 09/25/2026 at 09:09, 3 hours 15 minutes ago flatexDEGIRO sets course for next phase of growth
Published on 09/25/2026 at 09:08, 3 hours 16 minutes ago EQS-Adhoc: flatexDEGIRO expands Management Board
Published on 09/25/2026 at 07:00, 5 hours 24 minutes ago ENGIE mobilise une aide exceptionnelle de 54 millions d'euros pour soutenir les ménages les plus fragiles face à la hausse des prix de l'énergie
Published on 09/24/2026 at 18:31, 17 hours 53 minutes ago LNA SANTE : Mise à disposition du rapport financier semestriel 2026
Published on 09/24/2026 at 18:00, 18 hours 24 minutes ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
Published on 09/24/2026 at 18:00, 18 hours 24 minutes ago GUILLEMOT CORPORATION : Mise à disposition du rapport financier semestriel au 30 juin 2026
